EMG Holdings’s AEON Biopharma AEON Stock Holding History

EMG Holdings’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-739	Closed	-$520K	–	243
2022 Q1	$520K	Sell	739 -303	-29%	-$213K	0.04%	156
2021 Q4	$729K	Buy	+1,042	New	+$733K	0.09%	125

Other funds holding AEON

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EMG Holdings's AEON Position: Q2 2022 in Review

EMG Holdings sold out of AEON Biopharma (AEON) in Q2 2022, closing a stake of 739 shares — an estimated $520K sold.

EMG Holdings first reported a position in AEON in Q4 2021 and held it in 2 quarters. The position peaked at $729K in Q4 2021. 73 funds tracked by Wall St. Rank hold AEON as of Q2 2022.

EMG Holdings reported no remaining AEON Biopharma position as of Q2 2022 after selling out during the quarter.
EMG Holdings sold 739 AEON Biopharma shares in Q2 2022, an estimated $520K.
EMG Holdings first reported a position in AEON Biopharma in Q4 2021 and held it in 2 quarters.
EMG Holdings's AEON Biopharma position peaked at $729K in Q4 2021.
73 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2022.

Based on EMG Holdings's 13F filing for Q2 2022, filed 11 Aug 2022.